From Prodromal to Preclinical: Detecting Amyloid‐Beta Through Mobile Gaze Analysis

Abstract

Background: The accumulation of amyloid‐beta (Aβ) characterises Alzheimer's disease (AD) functioning as an essential biomarker for diagnosis and progression monitoring. Positron Emission Tomography (PET) imaging represents an established method for this.

The paper